Lv11
86 积分 2025-04-15 加入
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
2小时前
已完结
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
1个月前
已完结
Ribociclib plus Endocrine Therapy in Early Breast Cancer
3个月前
已完结
Advances in systemic therapies for triple negative breast cancer
4个月前
已完结
皖公网安备34019202002308
